nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Lenalidomide—hematologic cancer	0.187	0.35	CbGbCtD
Risedronate—PTGS2—Thalidomide—hematologic cancer	0.1	0.187	CbGbCtD
Risedronate—PTGS2—Triamcinolone—hematologic cancer	0.0694	0.129	CbGbCtD
Risedronate—PTGS2—Betamethasone—hematologic cancer	0.0595	0.111	CbGbCtD
Risedronate—PTGS2—Cisplatin—hematologic cancer	0.0429	0.08	CbGbCtD
Risedronate—PTGS2—Etoposide—hematologic cancer	0.0421	0.0786	CbGbCtD
Risedronate—PTGS2—Dexamethasone—hematologic cancer	0.0346	0.0646	CbGbCtD
Risedronate—PTGS2—ovarian follicle—hematologic cancer	0.0147	0.352	CbGeAlD
Risedronate—FDPS—hematopoietic system—hematologic cancer	0.00463	0.111	CbGeAlD
Risedronate—FDPS—gonad—hematologic cancer	0.00352	0.0843	CbGeAlD
Risedronate—FDPS—blood—hematologic cancer	0.00306	0.0734	CbGeAlD
Risedronate—FDPS—bone marrow—hematologic cancer	0.00297	0.071	CbGeAlD
Risedronate—FDPS—lung—hematologic cancer	0.00269	0.0644	CbGeAlD
Risedronate—FDPS—testis—hematologic cancer	0.00254	0.0607	CbGeAlD
Risedronate—FDPS—lymph node—hematologic cancer	0.00184	0.044	CbGeAlD
Risedronate—PTGS2—hematopoietic system—hematologic cancer	0.00177	0.0425	CbGeAlD
Risedronate—PTGS2—blood—hematologic cancer	0.00117	0.0281	CbGeAlD
Risedronate—PTGS2—bone marrow—hematologic cancer	0.00114	0.0272	CbGeAlD
Risedronate—PTGS2—lung—hematologic cancer	0.00103	0.0247	CbGeAlD
Risedronate—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000773	0.209	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000773	0.209	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000755	0.205	CbGdCrCtD
Risedronate—PTGS2—lymph node—hematologic cancer	0.000704	0.0169	CbGeAlD
Risedronate—Histamine Phosphate—SLC22A1—hematologic cancer	0.000566	1	CrCbGaD
Risedronate—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000466	0.126	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000466	0.126	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000456	0.124	CbGdCrCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1A—hematologic cancer	6.48e-05	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	6.37e-05	0.000993	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	6.34e-05	0.000987	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PHYH—hematologic cancer	6.18e-05	0.000963	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GMPS—hematologic cancer	6.18e-05	0.000963	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FTCD—hematologic cancer	6.18e-05	0.000963	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—EP300—hematologic cancer	6.17e-05	0.00096	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	6.12e-05	0.000953	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	6.11e-05	0.000952	CbGpPWpGaD
Risedronate—PTGS2—Disease—B3GAT1—hematologic cancer	5.9e-05	0.000919	CbGpPWpGaD
Risedronate—PTGS2—Disease—CHMP5—hematologic cancer	5.9e-05	0.000919	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—hematologic cancer	5.89e-05	0.000918	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.84e-05	0.00091	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	5.83e-05	0.000908	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—NRAS—hematologic cancer	5.77e-05	0.000898	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	5.76e-05	0.000898	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTP1—hematologic cancer	5.76e-05	0.000897	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	5.69e-05	0.000886	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SMPD3—hematologic cancer	5.65e-05	0.000881	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	5.64e-05	0.000878	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.57e-05	0.000868	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	5.46e-05	0.00085	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCB1—hematologic cancer	5.45e-05	0.000849	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	5.4e-05	0.000841	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	5.38e-05	0.000837	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—MYC—hematologic cancer	5.37e-05	0.000837	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	5.35e-05	0.000834	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDKN1B—hematologic cancer	5.35e-05	0.000833	CbGpPWpGaD
Risedronate—PTGS2—Disease—HDAC11—hematologic cancer	5.34e-05	0.000831	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—hematologic cancer	5.29e-05	0.000824	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NCOR1—hematologic cancer	5.29e-05	0.000824	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	5.27e-05	0.000821	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—hematologic cancer	5.26e-05	0.000819	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—hematologic cancer	5.24e-05	0.000817	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—hematologic cancer	5.24e-05	0.000816	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	5.23e-05	0.000814	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	5.23e-05	0.000814	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	5.14e-05	0.0008	CbGpPWpGaD
Risedronate—PTGS2—Disease—LIG4—hematologic cancer	5.12e-05	0.000797	CbGpPWpGaD
Risedronate—PTGS2—Disease—BCR—hematologic cancer	5.12e-05	0.000797	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCND1—hematologic cancer	5.1e-05	0.000795	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KRAS—hematologic cancer	4.96e-05	0.000773	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DCK—hematologic cancer	4.94e-05	0.00077	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ASNS—hematologic cancer	4.94e-05	0.00077	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—B3GAT1—hematologic cancer	4.94e-05	0.00077	CbGpPWpGaD
Risedronate—PTGS2—Disease—PC—hematologic cancer	4.92e-05	0.000767	CbGpPWpGaD
Risedronate—PTGS2—Disease—PSIP1—hematologic cancer	4.92e-05	0.000767	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.83e-05	0.000752	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—hematologic cancer	4.82e-05	0.000751	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.82e-05	0.00075	CbGpPWpGaD
Risedronate—PTGS2—Disease—HDAC10—hematologic cancer	4.76e-05	0.000741	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC35B2—hematologic cancer	4.76e-05	0.000741	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4.71e-05	0.000734	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.69e-05	0.000731	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HDC—hematologic cancer	4.68e-05	0.00073	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—hematologic cancer	4.68e-05	0.000729	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	4.48e-05	0.000698	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.37e-05	0.00068	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CDA—hematologic cancer	4.28e-05	0.000667	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.26e-05	0.000664	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	4.22e-05	0.000657	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	4.21e-05	0.000656	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PC—hematologic cancer	4.12e-05	0.000642	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.12e-05	0.000642	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	4.09e-05	0.000638	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	4.08e-05	0.000636	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	4.04e-05	0.00063	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.99e-05	0.000621	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC35B2—hematologic cancer	3.98e-05	0.00062	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GBA—hematologic cancer	3.98e-05	0.00062	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CG—hematologic cancer	3.93e-05	0.000612	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	3.89e-05	0.000606	CbGpPWpGaD
Risedronate—Myalgia—Prednisone—hematologic cancer	3.85e-05	0.000109	CcSEcCtD
Risedronate—Diarrhoea—Cisplatin—hematologic cancer	3.84e-05	0.000109	CcSEcCtD
Risedronate—Anxiety—Prednisone—hematologic cancer	3.83e-05	0.000108	CcSEcCtD
Risedronate—Vomiting—Gemcitabine—hematologic cancer	3.83e-05	0.000108	CcSEcCtD
Risedronate—Insomnia—Dexamethasone—hematologic cancer	3.83e-05	0.000108	CcSEcCtD
Risedronate—Insomnia—Betamethasone—hematologic cancer	3.83e-05	0.000108	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.82e-05	0.000108	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	3.81e-05	0.000594	CbGpPWpGaD
Risedronate—Paraesthesia—Betamethasone—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Risedronate—Paraesthesia—Dexamethasone—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Risedronate—PTGS2—Disease—SNCA—hematologic cancer	3.8e-05	0.000592	CbGpPWpGaD
Risedronate—PTGS2—Disease—AGRN—hematologic cancer	3.8e-05	0.000592	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPLP1—hematologic cancer	3.8e-05	0.000592	CbGpPWpGaD
Risedronate—Mental disorder—Methotrexate—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Risedronate—Rash—Gemcitabine—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Risedronate—Dermatitis—Gemcitabine—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—hematologic cancer	3.79e-05	0.000107	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—hematologic cancer	3.79e-05	0.000107	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—hematologic cancer	3.79e-05	0.000107	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Risedronate—Headache—Gemcitabine—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Risedronate—Nausea—Vincristine—hematologic cancer	3.77e-05	0.000107	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—hematologic cancer	3.77e-05	0.000107	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—hematologic cancer	3.77e-05	0.000106	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—hematologic cancer	3.76e-05	0.000106	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—hematologic cancer	3.74e-05	0.000106	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—hematologic cancer	3.73e-05	0.000105	CcSEcCtD
Risedronate—Dyspepsia—Betamethasone—hematologic cancer	3.73e-05	0.000105	CcSEcCtD
Risedronate—Dyspepsia—Dexamethasone—hematologic cancer	3.73e-05	0.000105	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—hematologic cancer	3.71e-05	0.000105	CcSEcCtD
Risedronate—Urticaria—Triamcinolone—hematologic cancer	3.71e-05	0.000105	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—hematologic cancer	3.7e-05	0.000105	CcSEcCtD
Risedronate—Asthenia—Etoposide—hematologic cancer	3.69e-05	0.000104	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000104	CcSEcCtD
Risedronate—Body temperature increased—Triamcinolone—hematologic cancer	3.69e-05	0.000104	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—hematologic cancer	3.68e-05	0.000104	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—hematologic cancer	3.68e-05	0.000104	CcSEcCtD
Risedronate—Nausea—Irinotecan—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Risedronate—Nausea—Mitoxantrone—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Risedronate—PTGS2—Disease—LEF1—hematologic cancer	3.67e-05	0.000571	CbGpPWpGaD
Risedronate—Infection—Prednisone—hematologic cancer	3.66e-05	0.000104	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—hematologic cancer	3.66e-05	0.000103	CcSEcCtD
Risedronate—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.66e-05	0.000103	CcSEcCtD
Risedronate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.66e-05	0.000103	CcSEcCtD
Risedronate—Back pain—Methotrexate—hematologic cancer	3.65e-05	0.000103	CcSEcCtD
Risedronate—Fatigue—Betamethasone—hematologic cancer	3.65e-05	0.000103	CcSEcCtD
Risedronate—Fatigue—Dexamethasone—hematologic cancer	3.65e-05	0.000103	CcSEcCtD
Risedronate—FDPS—Metabolism—CREBBP—hematologic cancer	3.64e-05	0.000568	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTAP—hematologic cancer	3.64e-05	0.000567	CbGpPWpGaD
Risedronate—Pruritus—Etoposide—hematologic cancer	3.64e-05	0.000103	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.64e-05	0.000567	CbGpPWpGaD
Risedronate—Shock—Prednisone—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Risedronate—Pain—Betamethasone—hematologic cancer	3.62e-05	0.000102	CcSEcCtD
Risedronate—Pain—Dexamethasone—hematologic cancer	3.62e-05	0.000102	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—hematologic cancer	3.62e-05	0.000102	CcSEcCtD
Risedronate—PTGS2—Disease—HMMR—hematologic cancer	3.6e-05	0.000561	CbGpPWpGaD
Risedronate—Skin disorder—Prednisone—hematologic cancer	3.58e-05	0.000101	CcSEcCtD
Risedronate—Nausea—Gemcitabine—hematologic cancer	3.58e-05	0.000101	CcSEcCtD
Risedronate—Vomiting—Cisplatin—hematologic cancer	3.57e-05	0.000101	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.57e-05	0.000556	CbGpPWpGaD
Risedronate—Mental disorder—Epirubicin—hematologic cancer	3.56e-05	0.000101	CcSEcCtD
Risedronate—Rash—Cisplatin—hematologic cancer	3.54e-05	0.0001	CcSEcCtD
Risedronate—Dermatitis—Cisplatin—hematologic cancer	3.54e-05	0.0001	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—hematologic cancer	3.53e-05	9.99e-05	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—hematologic cancer	3.52e-05	9.95e-05	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—hematologic cancer	3.51e-05	9.92e-05	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—hematologic cancer	3.5e-05	9.9e-05	CcSEcCtD
Risedronate—Anaemia—Methotrexate—hematologic cancer	3.49e-05	9.87e-05	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—hematologic cancer	3.49e-05	9.86e-05	CcSEcCtD
Risedronate—Flatulence—Epirubicin—hematologic cancer	3.48e-05	9.84e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.47e-05	0.000541	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.46e-05	0.00054	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Betamethasone—hematologic cancer	3.46e-05	9.79e-05	CcSEcCtD
Risedronate—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.46e-05	9.79e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—PIK3CD—hematologic cancer	3.45e-05	0.000538	CbGpPWpGaD
Risedronate—Hypersensitivity—Triamcinolone—hematologic cancer	3.44e-05	9.72e-05	CcSEcCtD
Risedronate—Back pain—Epirubicin—hematologic cancer	3.42e-05	9.66e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—ALB—hematologic cancer	3.41e-05	0.000531	CbGpPWpGaD
Risedronate—Angiopathy—Doxorubicin—hematologic cancer	3.41e-05	9.63e-05	CcSEcCtD
Risedronate—Dizziness—Etoposide—hematologic cancer	3.4e-05	9.62e-05	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—hematologic cancer	3.4e-05	9.6e-05	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—hematologic cancer	3.39e-05	9.59e-05	CcSEcCtD
Risedronate—Vertigo—Methotrexate—hematologic cancer	3.39e-05	9.59e-05	CcSEcCtD
Risedronate—PTGS2—Disease—ELL—hematologic cancer	3.39e-05	0.000528	CbGpPWpGaD
Risedronate—Mediastinal disorder—Doxorubicin—hematologic cancer	3.39e-05	9.57e-05	CcSEcCtD
Risedronate—Urticaria—Dexamethasone—hematologic cancer	3.36e-05	9.51e-05	CcSEcCtD
Risedronate—Urticaria—Betamethasone—hematologic cancer	3.36e-05	9.51e-05	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	3.36e-05	0.000524	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.36e-05	9.5e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.36e-05	0.000523	CbGpPWpGaD
Risedronate—Dizziness—Prednisolone—hematologic cancer	3.36e-05	9.49e-05	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—hematologic cancer	3.36e-05	9.49e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.35e-05	0.000522	CbGpPWpGaD
Risedronate—Asthenia—Triamcinolone—hematologic cancer	3.35e-05	9.47e-05	CcSEcCtD
Risedronate—Abdominal pain—Dexamethasone—hematologic cancer	3.35e-05	9.46e-05	CcSEcCtD
Risedronate—Body temperature increased—Dexamethasone—hematologic cancer	3.35e-05	9.46e-05	CcSEcCtD
Risedronate—Abdominal pain—Betamethasone—hematologic cancer	3.35e-05	9.46e-05	CcSEcCtD
Risedronate—Body temperature increased—Betamethasone—hematologic cancer	3.35e-05	9.46e-05	CcSEcCtD
Risedronate—Nausea—Cisplatin—hematologic cancer	3.34e-05	9.43e-05	CcSEcCtD
Risedronate—Insomnia—Prednisone—hematologic cancer	3.34e-05	9.43e-05	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—hematologic cancer	3.31e-05	9.36e-05	CcSEcCtD
Risedronate—Pruritus—Triamcinolone—hematologic cancer	3.3e-05	9.33e-05	CcSEcCtD
Risedronate—PTGS2—Disease—ACP5—hematologic cancer	3.3e-05	0.000513	CbGpPWpGaD
Risedronate—Cough—Methotrexate—hematologic cancer	3.3e-05	9.32e-05	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—hematologic cancer	3.29e-05	9.3e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.28e-05	0.000511	CbGpPWpGaD
Risedronate—Vomiting—Etoposide—hematologic cancer	3.27e-05	9.25e-05	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—hematologic cancer	3.27e-05	9.24e-05	CcSEcCtD
Risedronate—Anaemia—Epirubicin—hematologic cancer	3.27e-05	9.23e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—PIK3R1—hematologic cancer	3.26e-05	0.000508	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCOR2—hematologic cancer	3.25e-05	0.000507	CbGpPWpGaD
Risedronate—Dyspepsia—Prednisone—hematologic cancer	3.25e-05	9.18e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—FHL2—hematologic cancer	3.25e-05	0.000506	CbGpPWpGaD
Risedronate—Rash—Etoposide—hematologic cancer	3.24e-05	9.17e-05	CcSEcCtD
Risedronate—Dermatitis—Etoposide—hematologic cancer	3.24e-05	9.16e-05	CcSEcCtD
Risedronate—Headache—Etoposide—hematologic cancer	3.22e-05	9.11e-05	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—hematologic cancer	3.22e-05	9.11e-05	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—hematologic cancer	3.22e-05	9.09e-05	CcSEcCtD
Risedronate—Chest pain—Methotrexate—hematologic cancer	3.22e-05	9.09e-05	CcSEcCtD
Risedronate—Myalgia—Methotrexate—hematologic cancer	3.22e-05	9.09e-05	CcSEcCtD
Risedronate—Rash—Prednisolone—hematologic cancer	3.2e-05	9.05e-05	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—hematologic cancer	3.2e-05	9.04e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.2e-05	0.000498	CbGpPWpGaD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.19e-05	9.03e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—AGRN—hematologic cancer	3.18e-05	0.000496	CbGpPWpGaD
Risedronate—Fatigue—Prednisone—hematologic cancer	3.18e-05	8.99e-05	CcSEcCtD
Risedronate—Headache—Prednisolone—hematologic cancer	3.18e-05	8.99e-05	CcSEcCtD
Risedronate—Vertigo—Epirubicin—hematologic cancer	3.18e-05	8.98e-05	CcSEcCtD
Risedronate—Syncope—Epirubicin—hematologic cancer	3.17e-05	8.96e-05	CcSEcCtD
Risedronate—Back pain—Doxorubicin—hematologic cancer	3.16e-05	8.94e-05	CcSEcCtD
Risedronate—Constipation—Prednisone—hematologic cancer	3.15e-05	8.91e-05	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—hematologic cancer	3.14e-05	8.89e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.11e-05	0.000484	CbGpPWpGaD
Risedronate—Loss of consciousness—Epirubicin—hematologic cancer	3.11e-05	8.78e-05	CcSEcCtD
Risedronate—PTGS2—Disease—IDH1—hematologic cancer	3.1e-05	0.000483	CbGpPWpGaD
Risedronate—Dizziness—Triamcinolone—hematologic cancer	3.09e-05	8.72e-05	CcSEcCtD
Risedronate—Cough—Epirubicin—hematologic cancer	3.08e-05	8.72e-05	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	3.08e-05	0.000479	CbGpPWpGaD
Risedronate—PTGS2—Disease—GSTO1—hematologic cancer	3.06e-05	0.000477	CbGpPWpGaD
Risedronate—Infection—Methotrexate—hematologic cancer	3.06e-05	8.66e-05	CcSEcCtD
Risedronate—Nausea—Etoposide—hematologic cancer	3.06e-05	8.64e-05	CcSEcCtD
Risedronate—Hypertension—Epirubicin—hematologic cancer	3.05e-05	8.63e-05	CcSEcCtD
Risedronate—Asthenia—Betamethasone—hematologic cancer	3.04e-05	8.59e-05	CcSEcCtD
Risedronate—Asthenia—Dexamethasone—hematologic cancer	3.04e-05	8.59e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.03e-05	0.000471	CbGpPWpGaD
Risedronate—Nervous system disorder—Methotrexate—hematologic cancer	3.02e-05	8.54e-05	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—hematologic cancer	3.02e-05	8.54e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—HMMR—hematologic cancer	3.02e-05	0.00047	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—IDH2—hematologic cancer	3.02e-05	0.00047	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Prednisone—hematologic cancer	3.02e-05	8.52e-05	CcSEcCtD
Risedronate—Nausea—Prednisolone—hematologic cancer	3.01e-05	8.52e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—PIK3CB—hematologic cancer	3.01e-05	0.000469	CbGpPWpGaD
Risedronate—Arthralgia—Epirubicin—hematologic cancer	3.01e-05	8.51e-05	CcSEcCtD
Risedronate—Chest pain—Epirubicin—hematologic cancer	3.01e-05	8.51e-05	CcSEcCtD
Risedronate—Myalgia—Epirubicin—hematologic cancer	3.01e-05	8.51e-05	CcSEcCtD
Risedronate—PTGS2—Disease—AGO2—hematologic cancer	3e-05	0.000467	CbGpPWpGaD
Risedronate—Anxiety—Epirubicin—hematologic cancer	3e-05	8.48e-05	CcSEcCtD
Risedronate—Pruritus—Betamethasone—hematologic cancer	3e-05	8.47e-05	CcSEcCtD
Risedronate—Pruritus—Dexamethasone—hematologic cancer	3e-05	8.47e-05	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—hematologic cancer	2.99e-05	8.46e-05	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.99e-05	8.45e-05	CcSEcCtD
Risedronate—PTGS2—Disease—HDAC9—hematologic cancer	2.97e-05	0.000462	CbGpPWpGaD
Risedronate—Vomiting—Triamcinolone—hematologic cancer	2.97e-05	8.39e-05	CcSEcCtD
Risedronate—Rash—Triamcinolone—hematologic cancer	2.94e-05	8.32e-05	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—hematologic cancer	2.94e-05	8.32e-05	CcSEcCtD
Risedronate—Dermatitis—Triamcinolone—hematologic cancer	2.94e-05	8.31e-05	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—hematologic cancer	2.94e-05	8.31e-05	CcSEcCtD
Risedronate—PTGS2—Disease—H3F3B—hematologic cancer	2.94e-05	0.000458	CbGpPWpGaD
Risedronate—Syncope—Doxorubicin—hematologic cancer	2.93e-05	8.29e-05	CcSEcCtD
Risedronate—Urticaria—Prednisone—hematologic cancer	2.93e-05	8.28e-05	CcSEcCtD
Risedronate—Headache—Triamcinolone—hematologic cancer	2.92e-05	8.27e-05	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—hematologic cancer	2.92e-05	8.24e-05	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—hematologic cancer	2.92e-05	8.24e-05	CcSEcCtD
Risedronate—Diarrhoea—Betamethasone—hematologic cancer	2.9e-05	8.19e-05	CcSEcCtD
Risedronate—Diarrhoea—Dexamethasone—hematologic cancer	2.9e-05	8.19e-05	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—hematologic cancer	2.87e-05	8.12e-05	CcSEcCtD
Risedronate—Infection—Epirubicin—hematologic cancer	2.87e-05	8.1e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.86e-05	0.000446	CbGpPWpGaD
Risedronate—Cough—Doxorubicin—hematologic cancer	2.85e-05	8.07e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.85e-05	0.000443	CbGpPWpGaD
Risedronate—Shock—Epirubicin—hematologic cancer	2.84e-05	8.02e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—ARNTL—hematologic cancer	2.84e-05	0.000442	CbGpPWpGaD
Risedronate—Nervous system disorder—Epirubicin—hematologic cancer	2.83e-05	8e-05	CcSEcCtD
Risedronate—PTGS2—Disease—NPM1—hematologic cancer	2.83e-05	0.000441	CbGpPWpGaD
Risedronate—Hypertension—Doxorubicin—hematologic cancer	2.82e-05	7.98e-05	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.81e-05	7.94e-05	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—hematologic cancer	2.8e-05	7.92e-05	CcSEcCtD
Risedronate—Dizziness—Betamethasone—hematologic cancer	2.8e-05	7.92e-05	CcSEcCtD
Risedronate—Dizziness—Dexamethasone—hematologic cancer	2.8e-05	7.92e-05	CcSEcCtD
Risedronate—Insomnia—Methotrexate—hematologic cancer	2.79e-05	7.88e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.78e-05	0.000434	CbGpPWpGaD
Risedronate—Chest pain—Doxorubicin—hematologic cancer	2.78e-05	7.87e-05	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—hematologic cancer	2.78e-05	7.87e-05	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—hematologic cancer	2.78e-05	7.87e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.78e-05	0.000433	CbGpPWpGaD
Risedronate—Anxiety—Doxorubicin—hematologic cancer	2.77e-05	7.84e-05	CcSEcCtD
Risedronate—Nausea—Triamcinolone—hematologic cancer	2.77e-05	7.84e-05	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—hematologic cancer	2.77e-05	7.82e-05	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.77e-05	7.82e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—CA9—hematologic cancer	2.76e-05	0.00043	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ACP5—hematologic cancer	2.76e-05	0.00043	CbGpPWpGaD
Risedronate—Dyspnoea—Methotrexate—hematologic cancer	2.75e-05	7.77e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—NCOR2—hematologic cancer	2.72e-05	0.000424	CbGpPWpGaD
Risedronate—Dry mouth—Doxorubicin—hematologic cancer	2.72e-05	7.7e-05	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—hematologic cancer	2.72e-05	7.68e-05	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—hematologic cancer	2.71e-05	7.67e-05	CcSEcCtD
Risedronate—PTGS2—Disease—FGF19—hematologic cancer	2.71e-05	0.000422	CbGpPWpGaD
Risedronate—Vomiting—Betamethasone—hematologic cancer	2.69e-05	7.61e-05	CcSEcCtD
Risedronate—Vomiting—Dexamethasone—hematologic cancer	2.69e-05	7.61e-05	CcSEcCtD
Risedronate—PTGS2—Disease—RPS14—hematologic cancer	2.69e-05	0.000419	CbGpPWpGaD
Risedronate—Rash—Betamethasone—hematologic cancer	2.67e-05	7.55e-05	CcSEcCtD
Risedronate—Rash—Dexamethasone—hematologic cancer	2.67e-05	7.55e-05	CcSEcCtD
Risedronate—Dermatitis—Dexamethasone—hematologic cancer	2.67e-05	7.54e-05	CcSEcCtD
Risedronate—Dermatitis—Betamethasone—hematologic cancer	2.67e-05	7.54e-05	CcSEcCtD
Risedronate—PTGS2—Disease—DKK1—hematologic cancer	2.67e-05	0.000415	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.66e-05	7.52e-05	CcSEcCtD
Risedronate—Fatigue—Methotrexate—hematologic cancer	2.66e-05	7.51e-05	CcSEcCtD
Risedronate—Headache—Betamethasone—hematologic cancer	2.65e-05	7.5e-05	CcSEcCtD
Risedronate—Headache—Dexamethasone—hematologic cancer	2.65e-05	7.5e-05	CcSEcCtD
Risedronate—Infection—Doxorubicin—hematologic cancer	2.65e-05	7.49e-05	CcSEcCtD
Risedronate—Asthenia—Prednisone—hematologic cancer	2.65e-05	7.48e-05	CcSEcCtD
Risedronate—PTGS2—Disease—NUP98—hematologic cancer	2.65e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT5B—hematologic cancer	2.65e-05	0.000412	CbGpPWpGaD
Risedronate—Pain—Methotrexate—hematologic cancer	2.64e-05	7.45e-05	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.63e-05	7.43e-05	CcSEcCtD
Risedronate—Shock—Doxorubicin—hematologic cancer	2.63e-05	7.42e-05	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—hematologic cancer	2.62e-05	7.4e-05	CcSEcCtD
Risedronate—Pruritus—Prednisone—hematologic cancer	2.61e-05	7.38e-05	CcSEcCtD
Risedronate—Insomnia—Epirubicin—hematologic cancer	2.61e-05	7.37e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—PTEN—hematologic cancer	2.6e-05	0.000405	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—IDH1—hematologic cancer	2.6e-05	0.000404	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.59e-05	0.000404	CbGpPWpGaD
Risedronate—Skin disorder—Doxorubicin—hematologic cancer	2.59e-05	7.33e-05	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—hematologic cancer	2.59e-05	7.32e-05	CcSEcCtD
Risedronate—PTGS2—Disease—CST3—hematologic cancer	2.59e-05	0.000403	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.57e-05	0.000401	CbGpPWpGaD
Risedronate—Dyspnoea—Epirubicin—hematologic cancer	2.57e-05	7.27e-05	CcSEcCtD
Risedronate—PTGS2—Disease—ADCY7—hematologic cancer	2.57e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTO1—hematologic cancer	2.57e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCC3—hematologic cancer	2.57e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TXN—hematologic cancer	2.57e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Disease—NUP214—hematologic cancer	2.55e-05	0.000397	CbGpPWpGaD
Risedronate—Dyspepsia—Epirubicin—hematologic cancer	2.54e-05	7.18e-05	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—hematologic cancer	2.52e-05	7.13e-05	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—hematologic cancer	2.52e-05	7.12e-05	CcSEcCtD
Risedronate—Nausea—Dexamethasone—hematologic cancer	2.52e-05	7.11e-05	CcSEcCtD
Risedronate—Nausea—Betamethasone—hematologic cancer	2.52e-05	7.11e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—SPHK1—hematologic cancer	2.51e-05	0.000391	CbGpPWpGaD
Risedronate—PTGS2—Disease—XIAP—hematologic cancer	2.5e-05	0.000389	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTR—hematologic cancer	2.5e-05	0.000389	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.49e-05	7.04e-05	CcSEcCtD
Risedronate—Fatigue—Epirubicin—hematologic cancer	2.49e-05	7.03e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—EP300—hematologic cancer	2.48e-05	0.000387	CbGpPWpGaD
Risedronate—Pain—Epirubicin—hematologic cancer	2.47e-05	6.97e-05	CcSEcCtD
Risedronate—Constipation—Epirubicin—hematologic cancer	2.47e-05	6.97e-05	CcSEcCtD
Risedronate—PTGS2—Disease—ENO2—hematologic cancer	2.45e-05	0.000382	CbGpPWpGaD
Risedronate—Urticaria—Methotrexate—hematologic cancer	2.45e-05	6.92e-05	CcSEcCtD
Risedronate—Dizziness—Prednisone—hematologic cancer	2.44e-05	6.89e-05	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—hematologic cancer	2.44e-05	6.89e-05	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—hematologic cancer	2.44e-05	6.89e-05	CcSEcCtD
Risedronate—PTGS2—Disease—SMARCA4—hematologic cancer	2.43e-05	0.000379	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.43e-05	6.87e-05	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—hematologic cancer	2.41e-05	6.82e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.41e-05	0.000376	CbGpPWpGaD
Risedronate—Paraesthesia—Doxorubicin—hematologic cancer	2.4e-05	6.77e-05	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—hematologic cancer	2.38e-05	6.73e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.36e-05	0.000368	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Epirubicin—hematologic cancer	2.36e-05	6.67e-05	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—hematologic cancer	2.35e-05	6.64e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.35e-05	0.000366	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CRABP1—hematologic cancer	2.35e-05	0.000366	CbGpPWpGaD
Risedronate—Vomiting—Prednisone—hematologic cancer	2.35e-05	6.63e-05	CcSEcCtD
Risedronate—Rash—Prednisone—hematologic cancer	2.33e-05	6.57e-05	CcSEcCtD
Risedronate—Dermatitis—Prednisone—hematologic cancer	2.32e-05	6.57e-05	CcSEcCtD
Risedronate—PTGS2—Disease—SDC1—hematologic cancer	2.32e-05	0.000362	CbGpPWpGaD
Risedronate—Headache—Prednisone—hematologic cancer	2.31e-05	6.53e-05	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.3e-05	6.51e-05	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—hematologic cancer	2.3e-05	6.5e-05	CcSEcCtD
Risedronate—Urticaria—Epirubicin—hematologic cancer	2.29e-05	6.48e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—ALOX5—hematologic cancer	2.29e-05	0.000356	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.29e-05	0.000356	CbGpPWpGaD
Risedronate—Constipation—Doxorubicin—hematologic cancer	2.28e-05	6.45e-05	CcSEcCtD
Risedronate—Pain—Doxorubicin—hematologic cancer	2.28e-05	6.45e-05	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—hematologic cancer	2.28e-05	6.45e-05	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—hematologic cancer	2.28e-05	6.45e-05	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—hematologic cancer	2.27e-05	6.42e-05	CcSEcCtD
Risedronate—PTGS2—Disease—LCK—hematologic cancer	2.25e-05	0.00035	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NUP98—hematologic cancer	2.22e-05	0.000345	CbGpPWpGaD
Risedronate—Asthenia—Methotrexate—hematologic cancer	2.21e-05	6.25e-05	CcSEcCtD
Risedronate—PTGS2—Disease—H3F3A—hematologic cancer	2.2e-05	0.000343	CbGpPWpGaD
Risedronate—Nausea—Prednisone—hematologic cancer	2.19e-05	6.19e-05	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.18e-05	6.17e-05	CcSEcCtD
Risedronate—Pruritus—Methotrexate—hematologic cancer	2.18e-05	6.16e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—ADCY7—hematologic cancer	2.15e-05	0.000335	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA3—hematologic cancer	2.15e-05	0.000335	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKCZ—hematologic cancer	2.14e-05	0.000334	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NUP214—hematologic cancer	2.14e-05	0.000333	CbGpPWpGaD
Risedronate—Hypersensitivity—Epirubicin—hematologic cancer	2.13e-05	6.01e-05	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—hematologic cancer	2.12e-05	5.99e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.11e-05	0.000329	CbGpPWpGaD
Risedronate—Body temperature increased—Doxorubicin—hematologic cancer	2.11e-05	5.96e-05	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—hematologic cancer	2.11e-05	5.96e-05	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—hematologic cancer	2.11e-05	5.96e-05	CcSEcCtD
Risedronate—PTGS2—Disease—CALR—hematologic cancer	2.11e-05	0.000328	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTR—hematologic cancer	2.09e-05	0.000326	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG2—hematologic cancer	2.09e-05	0.000326	CbGpPWpGaD
Risedronate—PTGS2—Disease—PARP1—hematologic cancer	2.07e-05	0.000322	CbGpPWpGaD
Risedronate—Asthenia—Epirubicin—hematologic cancer	2.07e-05	5.85e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—ENO2—hematologic cancer	2.05e-05	0.00032	CbGpPWpGaD
Risedronate—Pruritus—Epirubicin—hematologic cancer	2.04e-05	5.77e-05	CcSEcCtD
Risedronate—Dizziness—Methotrexate—hematologic cancer	2.04e-05	5.76e-05	CcSEcCtD
Risedronate—PTGS2—Disease—FBXW7—hematologic cancer	2.04e-05	0.000317	CbGpPWpGaD
Risedronate—PTGS2—Disease—CXCR4—hematologic cancer	2e-05	0.000311	CbGpPWpGaD
Risedronate—PTGS2—Disease—HDAC2—hematologic cancer	2e-05	0.000311	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTT1—hematologic cancer	1.99e-05	0.00031	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD44—hematologic cancer	1.97e-05	0.000308	CbGpPWpGaD
Risedronate—Diarrhoea—Epirubicin—hematologic cancer	1.97e-05	5.58e-05	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—hematologic cancer	1.97e-05	5.56e-05	CcSEcCtD
Risedronate—Vomiting—Methotrexate—hematologic cancer	1.96e-05	5.54e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.96e-05	0.000305	CbGpPWpGaD
Risedronate—PTGS2—Disease—CBL—hematologic cancer	1.95e-05	0.000303	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SDC1—hematologic cancer	1.94e-05	0.000303	CbGpPWpGaD
Risedronate—Rash—Methotrexate—hematologic cancer	1.94e-05	5.49e-05	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—hematologic cancer	1.94e-05	5.49e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.93e-05	0.000301	CbGpPWpGaD
Risedronate—Headache—Methotrexate—hematologic cancer	1.93e-05	5.46e-05	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—hematologic cancer	1.92e-05	5.41e-05	CcSEcCtD
Risedronate—Dizziness—Epirubicin—hematologic cancer	1.91e-05	5.39e-05	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—hematologic cancer	1.89e-05	5.34e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.86e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Disease—HSP90AA1—hematologic cancer	1.86e-05	0.000289	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CA—hematologic cancer	1.84e-05	0.000286	CbGpPWpGaD
Risedronate—Vomiting—Epirubicin—hematologic cancer	1.83e-05	5.18e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.83e-05	0.000286	CbGpPWpGaD
Risedronate—Nausea—Methotrexate—hematologic cancer	1.83e-05	5.18e-05	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—hematologic cancer	1.83e-05	5.16e-05	CcSEcCtD
Risedronate—Rash—Epirubicin—hematologic cancer	1.82e-05	5.14e-05	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—hematologic cancer	1.82e-05	5.14e-05	CcSEcCtD
Risedronate—Headache—Epirubicin—hematologic cancer	1.81e-05	5.11e-05	CcSEcCtD
Risedronate—PTGS2—Disease—STAT1—hematologic cancer	1.79e-05	0.000279	CbGpPWpGaD
Risedronate—Dizziness—Doxorubicin—hematologic cancer	1.77e-05	4.99e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.75e-05	0.000273	CbGpPWpGaD
Risedronate—Nausea—Epirubicin—hematologic cancer	1.71e-05	4.84e-05	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—hematologic cancer	1.7e-05	4.8e-05	CcSEcCtD
Risedronate—Rash—Doxorubicin—hematologic cancer	1.68e-05	4.76e-05	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—hematologic cancer	1.68e-05	4.75e-05	CcSEcCtD
Risedronate—PTGS2—Disease—GRB2—hematologic cancer	1.67e-05	0.000261	CbGpPWpGaD
Risedronate—Headache—Doxorubicin—hematologic cancer	1.67e-05	4.73e-05	CcSEcCtD
Risedronate—PTGS2—Disease—PDGFA—hematologic cancer	1.67e-05	0.00026	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NQO1—hematologic cancer	1.65e-05	0.000258	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD44—hematologic cancer	1.65e-05	0.000258	CbGpPWpGaD
Risedronate—PTGS2—Disease—KITLG—hematologic cancer	1.65e-05	0.000257	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.62e-05	0.000252	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT5A—hematologic cancer	1.61e-05	0.000251	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN2B—hematologic cancer	1.6e-05	0.000249	CbGpPWpGaD
Risedronate—Nausea—Doxorubicin—hematologic cancer	1.59e-05	4.48e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—CYCS—hematologic cancer	1.56e-05	0.000244	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.55e-05	0.000242	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD86—hematologic cancer	1.54e-05	0.00024	CbGpPWpGaD
Risedronate—PTGS2—Disease—HES1—hematologic cancer	1.52e-05	0.000237	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCOR1—hematologic cancer	1.51e-05	0.000236	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—hematologic cancer	1.5e-05	0.000234	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF1—hematologic cancer	1.5e-05	0.000233	CbGpPWpGaD
Risedronate—PTGS2—Disease—FOXO1—hematologic cancer	1.47e-05	0.00023	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFRB—hematologic cancer	1.47e-05	0.000229	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFRA—hematologic cancer	1.45e-05	0.000226	CbGpPWpGaD
Risedronate—PTGS2—Disease—JAK1—hematologic cancer	1.44e-05	0.000225	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKCG—hematologic cancer	1.44e-05	0.000225	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.4e-05	0.000218	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTP1—hematologic cancer	1.38e-05	0.000215	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—hematologic cancer	1.34e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.33e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Disease—HLA-A—hematologic cancer	1.33e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Disease—TERT—hematologic cancer	1.33e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—hematologic cancer	1.31e-05	0.000203	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFB—hematologic cancer	1.3e-05	0.000203	CbGpPWpGaD
Risedronate—PTGS2—Disease—TSC2—hematologic cancer	1.27e-05	0.000198	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—hematologic cancer	1.27e-05	0.000197	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOR1—hematologic cancer	1.27e-05	0.000197	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGFR3—hematologic cancer	1.22e-05	0.000191	CbGpPWpGaD
Risedronate—PTGS2—Disease—BAD—hematologic cancer	1.16e-05	0.000181	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOTCH1—hematologic cancer	1.15e-05	0.000179	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD80—hematologic cancer	1.13e-05	0.000175	CbGpPWpGaD
Risedronate—PTGS2—Disease—KIT—hematologic cancer	1.12e-05	0.000175	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—hematologic cancer	1.12e-05	0.000174	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTPN11—hematologic cancer	1.1e-05	0.000172	CbGpPWpGaD
Risedronate—PTGS2—Disease—CREB1—hematologic cancer	1.07e-05	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Disease—BRAF—hematologic cancer	1.06e-05	0.000165	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6R—hematologic cancer	1.04e-05	0.000163	CbGpPWpGaD
Risedronate—PTGS2—Disease—CREBBP—hematologic cancer	1.04e-05	0.000162	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAP2K1—hematologic cancer	9.95e-06	0.000155	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CD—hematologic cancer	9.88e-06	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.87e-06	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF2—hematologic cancer	9.46e-06	0.000147	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CG—hematologic cancer	9.41e-06	0.000147	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3R1—hematologic cancer	9.33e-06	0.000145	CbGpPWpGaD
Risedronate—PTGS2—Disease—JAK2—hematologic cancer	9.07e-06	0.000141	CbGpPWpGaD
Risedronate—PTGS2—Disease—MDM2—hematologic cancer	8.85e-06	0.000138	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CREBBP—hematologic cancer	8.73e-06	0.000136	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CB—hematologic cancer	8.61e-06	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTOR—hematologic cancer	8.61e-06	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—hematologic cancer	8.6e-06	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CD—hematologic cancer	8.27e-06	0.000129	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—hematologic cancer	8.17e-06	0.000127	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1B—hematologic cancer	8.08e-06	0.000126	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3R1—hematologic cancer	7.81e-06	0.000122	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1A—hematologic cancer	7.46e-06	0.000116	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—hematologic cancer	7.44e-06	0.000116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CB—hematologic cancer	7.21e-06	0.000112	CbGpPWpGaD
Risedronate—PTGS2—Disease—EP300—hematologic cancer	7.1e-06	0.000111	CbGpPWpGaD
Risedronate—PTGS2—Disease—SRC—hematologic cancer	6.9e-06	0.000107	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—hematologic cancer	6.66e-06	0.000104	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRAS—hematologic cancer	6.64e-06	0.000103	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—hematologic cancer	6.36e-06	9.9e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—hematologic cancer	6.23e-06	9.71e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYC—hematologic cancer	6.18e-06	9.63e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—hematologic cancer	6.17e-06	9.61e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—EP300—hematologic cancer	5.94e-06	9.26e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—hematologic cancer	5.71e-06	8.9e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CA—hematologic cancer	5.25e-06	8.18e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—hematologic cancer	4.86e-06	7.57e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—hematologic cancer	4.65e-06	7.24e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CA—hematologic cancer	4.4e-06	6.85e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—hematologic cancer	4.29e-06	6.68e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—hematologic cancer	3.59e-06	5.59e-05	CbGpPWpGaD
